Niger vs Sur: Hepatitis B surface antigen (HBsAg) prevalence
Niger
3.2%
in 2024
Sur
0.2%
in 2024
Niger rank
3rd
Sur rank
1st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Niger
- Sur
How they compare
Niger currently reports 3.2% against 0.2% in Sur, a difference of 3.0%.
That makes Niger's figure about 16.0 times Sur's.
Across all 10 years both countries report, Niger has been ahead every year.
Niger ranks 3rd and Sur ranks 1st of 194 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.2% | 2.4% | Niger |
| 2020s | 3.4% | 0.2% | 3.2% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Niger or Sur?
- Niger, at 3.2% against 0.2% in Sur as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Niger and Sur?
- 3.0%, with Niger ahead.
- How many years of comparable data are there for Niger and Sur?
- 10 years are reported by both, from 2015 to 2024.
- How do Niger and Sur rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Niger ranks 3rd and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.